Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Cassava Sciences Inc has a consensus price target of $51 based on the ratings of 4 analysts. The high is $107 issued by Rodman & Renshaw on August 8, 2024. The low is $2 issued by HC Wainwright & Co. on March 25, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on March 25, 2025, November 26, 2024, and November 8, 2024, respectively. With an average price target of $78 between HC Wainwright & Co., there's an implied 4071.12% upside for Cassava Sciences Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/25/2025 | Buy Now | 6.95% | HC Wainwright & Co. | Vernon Bernardino52% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
03/04/2025 | Buy Now | — | HC Wainwright & Co. | Vernon Bernardino52% | — | Reiterates | Neutral → Neutral | Get Alert |
11/26/2024 | Buy Now | 6103.21% | HC Wainwright & Co. | Vernon Bernardino52% | → $116 | Downgrade | Buy → Neutral | Get Alert |
11/08/2024 | Buy Now | 6103.21% | HC Wainwright & Co. | Vernon Bernardino52% | $116 → $116 | Reiterates | Buy → Buy | Get Alert |
10/08/2024 | Buy Now | 6103.21% | HC Wainwright & Co. | Vernon Bernardino52% | → $116 | Upgrade | Neutral → Buy | Get Alert |
08/13/2024 | Buy Now | — | HC Wainwright & Co. | Vernon Bernardino52% | — | Reiterates | → Neutral | Get Alert |
08/08/2024 | Buy Now | 5621.93% | Rodman & Renshaw | Elemer Piros56% | $107 → $107 | Reiterates | Buy → Buy | Get Alert |
07/19/2024 | Buy Now | — | HC Wainwright & Co. | Vernon Bernardino52% | — | Reiterates | → Neutral | Get Alert |
07/01/2024 | Buy Now | — | Jones Trading | Soumit Roy46% | — | Downgrade | Buy → Hold | Get Alert |
07/01/2024 | Buy Now | — | HC Wainwright & Co. | Vernon Bernardino52% | — | Downgrade | Buy → Neutral | Get Alert |
05/17/2024 | Buy Now | 6905.35% | HC Wainwright & Co. | Vernon Bernardino52% | $124 → $131 | Maintains | Buy | Get Alert |
03/05/2024 | Buy Now | 6531.02% | HC Wainwright & Co. | Vernon Bernardino52% | → $124 | Reiterates | Buy → Buy | Get Alert |
08/08/2023 | Buy Now | 6531.02% | HC Wainwright & Co. | Vernon Bernardino52% | → $124 | Reiterates | Buy → Buy | Get Alert |
07/06/2023 | Buy Now | 6531.02% | HC Wainwright & Co. | Vernon Bernardino52% | $124 → $124 | Reiterates | Buy → Buy | Get Alert |
05/11/2023 | Buy Now | 6531.02% | HC Wainwright & Co. | Vernon Bernardino52% | → $124 | Reiterates | Buy → Buy | Get Alert |
05/09/2023 | Buy Now | 6531.02% | HC Wainwright & Co. | Vernon Bernardino52% | → $124 | Reiterates | → Buy | Get Alert |
03/06/2023 | Buy Now | 6531.02% | HC Wainwright & Co. | Vernon Bernardino52% | → $124 | Reiterates | → Buy | Get Alert |
01/24/2023 | Buy Now | 6531.02% | HC Wainwright & Co. | Vernon Bernardino52% | → $124 | Reiterates | → Buy | Get Alert |
08/11/2022 | Buy Now | 2252.94% | B. Riley Securities | Mayank Mamtani71% | $58 → $44 | Maintains | Buy | Get Alert |
The latest price target for Cassava Sciences (NASDAQ:SAVA) was reported by HC Wainwright & Co. on March 25, 2025. The analyst firm set a price target for $2.00 expecting SAVA to rise to within 12 months (a possible 6.95% upside). 11 analyst firms have reported ratings in the last year.
The latest analyst rating for Cassava Sciences (NASDAQ:SAVA) was provided by HC Wainwright & Co., and Cassava Sciences reiterated their neutral rating.
The last upgrade for Cassava Sciences Inc happened on October 8, 2024 when HC Wainwright & Co. raised their price target to $116. HC Wainwright & Co. previously had a neutral for Cassava Sciences Inc.
The last downgrade for Cassava Sciences Inc happened on November 26, 2024 when HC Wainwright & Co. changed their price target from N/A to $116 for Cassava Sciences Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cassava Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cassava Sciences was filed on March 25, 2025 so you should expect the next rating to be made available sometime around March 25, 2026.
While ratings are subjective and will change, the latest Cassava Sciences (SAVA) rating was a reiterated with a price target of $2.00 to $2.00. The current price Cassava Sciences (SAVA) is trading at is $1.87, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.